VOYA Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,360
Closed -$91K 2952
2021
Q1
$91K Buy
18,360
+2,474
+16% +$11.9K ﹤0.01% 2687
2020
Q4
$68K Buy
15,886
+1,464
+10% +$5.96K ﹤0.01% 2628
2020
Q3
$62K Hold
14,422
﹤0.01% 2410
2020
Q2
$65K Sell
14,422
-4,122
-22% -$18.4K ﹤0.01% 2410
2020
Q1
$74K Hold
18,544
﹤0.01% 2416
2019
Q4
$157K Buy
18,544
+3,669
+25% +$28.6K ﹤0.01% 2449
2019
Q3
$102K Hold
14,875
﹤0.01% 2409
2019
Q2
$124K Buy
14,875
+2,130
+17% +$18.4K ﹤0.01% 2414
2019
Q1
$117K Hold
12,745
﹤0.01% 2393
2018
Q4
$140K Buy
12,745
+1,362
+12% +$17.2K ﹤0.01% 2327
2018
Q3
$159K Hold
11,383
﹤0.01% 2403
2018
Q2
$121K Hold
11,383
﹤0.01% 2483
2018
Q1
$98K Hold
11,383
﹤0.01% 2473
2017
Q4
$108K Hold
11,383
﹤0.01% 2491
2017
Q3
$89K Hold
11,383
﹤0.01% 2567
2017
Q2
$98K Buy
+11,383
New +$81.7K ﹤0.01% 2579

Other funds holding KIN

VOYA Investment Management's KIN Position: Q2 2021 in Review

VOYA Investment Management sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 18,360 shares — an estimated $91K sold.

VOYA Investment Management first reported a position in KIN in Q2 2017 and held it in 16 quarters. The position peaked at $159K in Q3 2018. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • VOYA Investment Management reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 18,360 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $91K.
  • VOYA Investment Management first reported a position in Kindred Biosciences, Inc. in Q2 2017 and held it in 16 quarters.
  • VOYA Investment Management's Kindred Biosciences, Inc. position peaked at $159K in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.